About Animal Growth Enhancers
Growth enhancers are stimulators that accelerate livestock growth. Antibiotics are primarily used as growth promoters and are administered as low and sub-therapeutic dose. The market comprises various growth stimulators, namely, antibiotics and feed. Animal antibiotics hold the largest market share attributed to the dual benefit of being able to prevent and cure bacterial infections and stimulating the growth of the livestock. The animal health industry has been witnessing substantial growth, mainly due to growing number of innovations and increasing number of strategies to prevent and control zoonotic and other infectious diseases in animals. An animal growth promoter is used to help animals digest their food more effectively and allow them to grow. These promoters can be any medicine that destroy or inhibit bacteria, and are administrated in a low dose. They improve an animal’s regular activity, health status, efficiency, and bring about uniformity in size. These growth enhancers are commonly used in livestock production globally.
Technavio’s analysts forecast the global animal growth enhancers market to grow at a CAGR of 5.99% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global animal growth enhancers market for 2017-2021. To calculate the market size, the report considers the sales of antibiotic, feed enzyme, and pre-and pro biotics products.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Animal Growth Enhancers Market 2017-2021
Technavio recognizes the following companies as the key players in the global animal growth enhancers market: Boehringer Ingelheim, Bayer, Elanco, and Zoetis
Other Prominent Vendors in the market are: Animal Medics, Biogénesis Bagó, Bio-Vet, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Mobedco, Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac, and Vitafor.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is R&D efforts for discovering natural growth promoters. The major trend in poultry production in the recent times is reducing the use of antibiotics and other medical products such as allopathic medication due to concerns over bacterial resistance. Therefore, researchers are focusing on developing alternative strategies such as natural growth promoters to maintain poultry health.”
According to the report, one of the major drivers for this market is Rising demand for poultry products in developed and developing nations. Increasing consumption of meat is driving the demand for animal growth enhancers. As the developing countries are increasingly keen on maintaining protein rich diets, meat consumption is expected to continue witnessing an uptrend over next few years.
Further, the report states that one of the major factors hindering the growth of this market is Disease outbreak in livestock. Disease outbreaks leading to epidemics affect animal health, and is a challenge to the growing economic trade cycle related to animal products. It also leads to loss of livestock products such as meat, milk, dairy and related products. Death of animals affect the economic cycle of farm owners, thus affecting the sales and revenue of the global animal growth enhancers market. Disease outbreaks disturb livestock product trade and inhibit sustained investment. The major disease outbreaks witnessed among livestock are foot-and-mouth disease, rinderpest, contagious bovine pleuropneumonia, rift valley fever, swine vesicular disease, sheep and goat pox, and fowl plague.
Boehringer Ingelheim, Bayer, Elanco, Zoetis, Animal Medics, Biogénesis Bagó, Bio-Vet, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Mobedco, Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac, and Vitafor.